Danta, Mark
3 papers on CoChatORCID 0000-0001-5551-6811
Most cited papers
- Verified
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Qin, S., Chen, M., Cheng, A.-L., Kaseb, A. O., Kudo, M., Lee, H. C., Yopp, A. C., Zhou, J., Wang, L., Wen, X., et al. (2023) · The Lancet
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers
Cited by 545
- Verified
Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.
Danta, M., Brown, D., Bhagani, S., Pybus, O. G., Sabin, C. A., Nelson, M., Fisher, M., Johnson, A. M., & Dusheiko, G. M. (2007) · AIDS
Hepatitis C virus researchHIV, Drug Use, Sexual Risk
Cited by 410
- Verified
Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM.
Lockart, I., Matthews, G. V., & Danta, M. (2019) · Current Opinion in Infectious Diseases
Hepatitis C virus researchHIV, Drug Use, Sexual Risk
Cited by 37
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free